Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.
Chung V, Alistar A, Becerra C, Kasi A, Borazanci E, Jameson GS, Roe DJ, Wertheim BC, Cridebring D, Truitt M, Downes M, Barrett MT, Korn R, Lee K, Han H, Evans R, Von Hoff DD.
Chung V, et al. Among authors: barrett mt.
Oncologist. 2025 Jan 17;30(1):oyae323. doi: 10.1093/oncolo/oyae323.
Oncologist. 2025.
PMID: 39846984
Free PMC article.
Clinical Trial.